Skip to main content
. 2020 Dec;9(6):2521–2534. doi: 10.21037/tlcr-20-331

Figure 1.

Figure 1

Timeline of FDA approvals for ALK TKIs. ALK, anaplastic lymphoma kinase; TKIs, tyrosine kinase inhibitors.